Clinical trials
Retinopathy clinical trials
Below are recruiting retinopathy clinical trials, each written for real people, not researchers. We’re tracking 116 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06943599Recruiting
Improving Eye Care After Screening
This study looks at better ways to help people get follow-up eye care after a screening. If you were in the VIEW II study and were referred to an eye hospital, this trial may offer strategies to support you in getting that care.
San Francisco, CaliforniaAges 60 years+ - NCT06968611Recruiting
Diabetes and vision care study in Bangladesh
This study tests a program that combines diabetes care with eye exams for people in Bangladesh who were recently diagnosed with diabetes. The goal is to see if this approach helps you better manage your health and prevent vision problems.
DinajpurAges 30 years+ - NCT06968637Recruiting
Improving diabetes and vision care in Bangladesh
This study tests a new way to combine diabetes care with eye care for people with diabetes in Bangladesh. If you have diabetes and a diabetes-related eye condition, this might help improve your care.
Dinajpur Sadar, DinajpurAges 30 years+ - NCT07002372Recruiting
Watching a video before your first eye injection
This study tests whether watching a short video before your first eye injection helps you feel more at ease. It is for people who have never had this injection before.
Hangzhou, ZhejiangAges 18 years+ - NCT07015034Recruiting
Preventing vision loss in older adults with chronic conditions
This study tests a model to help general practitioners find older patients who may be at risk of vision loss. It aims to spot problems early so treatment can start sooner.
Copenhagen, Capital RegionAges 70 years+ - NCT07093255RecruitingPhase 1
Testing FLQ-101 in premature newborns
This study tests an experimental medicine called FLQ-101 in very premature newborns to see how safe it is and how the body processes it. It may help babies who are born at 26 to 27 weeks of pregnancy.
Austin, TexasAges 4 days–5 days - NCT07222293Recruiting
Testing an AI tool to screen for diabetic eye disease
This study uses an AI program called DRISTi to screen for diabetic eye disease by taking pictures of the back of your eye. It's designed for adults with diabetes who haven't had major eye treatments or vision loss.
Oxford, North CarolinaAges 21 years+ - NCT05463289Recruiting
AI helps children with diabetes get eye exams
This study tests an AI-based way to help check children’s eyes for signs of diabetic retinopathy (diabetes-related eye disease). It may improve how quickly and consistently eye screening is done for kids with diabetes.
Baltimore, MarylandAges 8–21 - NCT07378956Recruiting
AI eye screening for diabetes patients
This study uses an artificial intelligence (AI) tool to analyze eye images in people with type 2 diabetes. The goal is to see if the AI can help detect early signs of diabetic eye disease, so you can get the right care sooner.
Incheon, Gyeonggi-doAges 19 years+ - NCT02026843Recruiting
Testing eye fluid markers in chorioretinal eye diseases
This study looks at substances (“biomarkers”) in the clear fluid inside the eye to better understand several eye conditions that affect vision. Your results may help doctors learn how these diseases work and how treatments might be chosen.
Daegu, KyungsangpookdoAges 20–80 - NCT01496625Recruiting
Biobank study for retinal diseases and comparison samples
This study collects and stores blood and eye-related medical information to help researchers better understand retinal diseases, including age-related macular degeneration and diabetic retinopathy. Your samples may also be used to compare people with retinal disease to people without it.
Bethesda, MarylandAges 2–120 - NCT03011541Recruiting
Stem cell treatment for damaged retina or optic nerve
This study looks at stem-cell treatment to help vision in adults whose retina or optic nerve damage is not expected to improve on its own. You may be a candidate if your eye exam shows documented, stable or slowly changing damage and you can safely complete follow-up eye visits.
Westport, ConnecticutAges 18 years+ - NCT07417410Recruiting
Diabetes eye disease risk study
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
Portugal, Coimbra DistrictAges 35–90 - NCT07555574Recruiting
New imaging technology to see retinal structures clearly
This research study tests a new camera technology that takes detailed pictures of the back of your eye (retina) to better understand eye diseases. Researchers want to compare images from people with eye conditions like diabetes-related eye disease, glaucoma, or age-related macular degeneration with healthy volunteers to see how the new imaging works.
Melbourne, VictoriaAges 18 years+ - NCT07456826Enrolling by invitationPhase 4
Comparing two eye numbing gels for shots
This trial tests a new eye-numbing gel against the standard numbing method to see which works better for patients getting regular anti-VEGF injections in the eye.
Tyler, TexasAges 18 years+ - NCT07378891Enrolling by invitation
AI eye screening for early diabetic retinopathy
This study uses artificial intelligence (AI) to look at photos of the back of your eye (retina) to find early signs of diabetic eye disease. It aims to catch problems before they worsen, so you can get treatment sooner.
TübingenAges 18–80 - NCT07334652Enrolling by invitation
Managing pain and comfort during eye exams for premature babies
This study tests different methods to manage pain and comfort in premature infants during their first eye exam for retinopathy of prematurity. It may help find ways to make the exam less stressful for babies.
Erzurum, YakutiyeAges birth–1 month - NCT07170683Enrolling by invitation
Vision test study for macular eye disorders
This study uses a special vision test called microperimetry to track how well the macula (the center of the retina) works in people with certain eye conditions like geographic atrophy or diabetic eye disease. Healthy volunteers are also needed for comparison. The goal is to understand how these conditions affect retinal function over time.
Nottingham, NottsAges 21 years+ - NCT06951087Enrolling by invitationPhase 3
Steroid injection for diabetic retinopathy with cataract surgery
This trial tests if an injection of dexamethasone (a steroid) into the eye, before or during cataract surgery, can help treat mild to moderate diabetic retinopathy in people with type 2 diabetes.
Nantong, JiangsuAges Any age - NCT05254535Enrolling by invitation
Tele-eye screening help for rural clinics with diabetes
This study tests whether adding a structured telehealth program (video eye checks) can improve diabetic eye screening in rural health systems. Your clinic may help the researchers measure changes using shared, de-identified patient data.
Madison, WisconsinAges 18 years+
Hear when a new Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for retinopathy?
- Yes. Clin2 currently lists 116 recruiting retinopathy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a retinopathy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a retinopathy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.